141 related articles for article (PubMed ID: 33864517)
1. Detection of activating mutations in liquid biopsy of Egyptian breast cancer patients using targeted next-generation sequencing: a pilot study.
Kassem N; Kassem H; Kassem L; Hassan M
J Egypt Natl Canc Inst; 2021 Apr; 33(1):10. PubMed ID: 33864517
[TBL] [Abstract][Full Text] [Related]
2. Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing.
Taher MM; Bantan NA; Alwalily MH; Saeed M; Taher NM; Bouzidi M; Jastania RA; Balkhoyour KB
Cureus; 2023 Jun; 15(6):e39818. PubMed ID: 37273678
[TBL] [Abstract][Full Text] [Related]
3. Targeted next generation sequencing identifies somatic mutations in a cohort of Egyptian breast cancer patients.
Nassar A; Abouelhoda M; Mansour O; Loutfy SA; Hafez MM; Gomaa M; Bahnassy A; El-Din Youssef AS; Lotfy MM; Ismail H; Ahmed OS; Abou-Bakr AA; Zekri AN
J Adv Res; 2020 Jul; 24():149-157. PubMed ID: 32322420
[TBL] [Abstract][Full Text] [Related]
4. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
5. Identification of PKHD1 mutations in Brain, Breast and Rectal tumors by Next Generation DNA Sequencing.
Mohammed Almehmadi D; Saleh Dairi A; Ali Hassan A; Dannoun A; Saleh Banni H; M Melibary E; Youssef AR; M Taher M
Gulf J Oncolog; 2021 Jan; 1(35):42-53. PubMed ID: 33716212
[TBL] [Abstract][Full Text] [Related]
6. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
F1000Res; 2019; 8():613. PubMed ID: 32612806
[No Abstract] [Full Text] [Related]
7. A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome.
Palmieri M; Pinto AM; di Blasio L; Currò A; Monica V; Sarno LD; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Mussolin B; Fallerini C; Molinaro F; Vaghi M; Renieri A; Primo L
Vascular; 2021 Feb; 29(1):85-91. PubMed ID: 32588787
[TBL] [Abstract][Full Text] [Related]
8. Applicability of next generation sequencing technology in microsatellite instability testing.
Gan C; Love C; Beshay V; Macrae F; Fox S; Waring P; Taylor G
Genes (Basel); 2015 Feb; 6(1):46-59. PubMed ID: 25685876
[TBL] [Abstract][Full Text] [Related]
9. Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing.
Kim JE; Chun SM; Hong YS; Kim KP; Kim SY; Kim J; Sung CO; Cho EJ; Kim TW; Jang SJ
J Mol Diagn; 2019 Mar; 21(2):241-250. PubMed ID: 30389464
[TBL] [Abstract][Full Text] [Related]
10. A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study.
Nunziato M; Esposito MV; Starnone F; Diroma MA; Calabrese A; Del Monaco V; Buono P; Frasci G; Botti G; D'Aiuto M; Salvatore F; D'Argenio V
Anal Chim Acta; 2019 Jan; 1046():154-162. PubMed ID: 30482293
[TBL] [Abstract][Full Text] [Related]
11. Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
Nakauchi C; Kagara N; Shimazu K; Shimomura A; Naoi Y; Shimoda M; Kim SJ; Noguchi S
Clin Breast Cancer; 2016 Oct; 16(5):418-423. PubMed ID: 27265061
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A
BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863
[TBL] [Abstract][Full Text] [Related]
13. Gene Panel Testing in Hereditary Breast Cancer.
Rostami P; Zendehdel K; Shirkoohi R; Ebrahimi E; Ataei M; Imanian H; Najmabadi H; Akbari MR; Sanati MH
Arch Iran Med; 2020 Mar; 23(3):155-162. PubMed ID: 32126783
[TBL] [Abstract][Full Text] [Related]
14. Next Generation Sequencing in Molecular Diagnosis of Lynch Syndrome - a Pilot Study Using New Stratification Criteria.
Kašubová I; Holubeková V; Janíková K; Váňová B; Sňahničanová Z; Kalman M; Plank L; Lasabová Z
Acta Medica (Hradec Kralove); 2018; 61(3):98-102. PubMed ID: 30543514
[TBL] [Abstract][Full Text] [Related]
15. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
[TBL] [Abstract][Full Text] [Related]
16. High throughput detection of microsatellite instability by denaturing high-performance liquid chromatography.
Pan KF; Liu W; Lu YY; Zhang L; Li ZP; Lu WL; Thibodeau SN; You WC
Hum Mutat; 2003 Nov; 22(5):388-94. PubMed ID: 14517950
[TBL] [Abstract][Full Text] [Related]
17. Targeted mutation detection in breast cancer using MammaSeq™.
Smith NG; Gyanchandani R; Shah OS; Gurda GT; Lucas PC; Hartmaier RJ; Brufsky AM; Puhalla S; Bahreini A; Kota K; Wald AI; Nikiforov YE; Nikiforova MN; Oesterreich S; Lee AV
Breast Cancer Res; 2019 Feb; 21(1):22. PubMed ID: 30736836
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
[TBL] [Abstract][Full Text] [Related]
19. Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.
Al Hannan F; Keogh MB; Taha S; Al Buainain L
Mol Genet Genomic Med; 2019 Jul; 7(7):e00771. PubMed ID: 31131559
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.
Akahane T; Kitazono I; Yanazume S; Kamio M; Togami S; Sakamoto I; Nohara S; Yokoyama S; Kobayashi H; Hiraki T; Suzuki S; Ueno S; Tanimoto A
BMC Med Genomics; 2020 Jul; 13(1):101. PubMed ID: 32652986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
